Sae Kamamoto

485 total citations
21 papers, 209 citations indexed

About

Sae Kamamoto is a scholar working on Pharmacology, Economics and Econometrics and General Health Professions. According to data from OpenAlex, Sae Kamamoto has authored 21 papers receiving a total of 209 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 11 papers in Economics and Econometrics and 8 papers in General Health Professions. Recurrent topics in Sae Kamamoto's work include Pharmaceutical industry and healthcare (19 papers), Pharmaceutical Economics and Policy (9 papers) and Healthcare cost, quality, practices (8 papers). Sae Kamamoto is often cited by papers focused on Pharmaceutical industry and healthcare (19 papers), Pharmaceutical Economics and Policy (9 papers) and Healthcare cost, quality, practices (8 papers). Sae Kamamoto collaborates with scholars based in Japan, United States and Malaysia. Sae Kamamoto's co-authors include Anju Murayama, Akihiko Ozaki, Hiroaki Saito, Tetsuya Tanimoto, Erika Yamashita, Eiji Kusumi, Toyoaki Sawano, Divya Bhandari, Piotr Ozierański and Ryota Yamasaki and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of the American Society of Nephrology.

In The Last Decade

Sae Kamamoto

21 papers receiving 209 citations

Peers

Countries citing papers authored by Sae Kamamoto

Since Specialization

Citations

This map shows the geographic impact of Sae Kamamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sae Kamamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sae Kamamoto more than expected).

Fields of papers citing papers by Sae Kamamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sae Kamamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sae Kamamoto. The network helps show where Sae Kamamoto may publish in the future.

Co-authorship network of co-authors of Sae Kamamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Sae Kamamoto. A scholar is included among the top collaborators of Sae Kamamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sae Kamamoto. Sae Kamamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmaceutical Payments to Japanese Board‐Certified Head and Neck Surgeons Between 2016 and 2019 2023 ·OTO Open ·Anju Murayama, (unknown), Sae Kamamoto, Erika Yamashita, Hiroaki Saito, Toyoaki Sawano, Divya Bhandari, Sunil Shrestha, Eiji Kusumi, Tetsuya Tanimoto, Akihiko Ozaki	6
2	Assessment of Financial Relationships Between Otorhinolaryngologists and Pharmaceutical Companies in Japan Between 2016 and 2019 2023 ·Cureus ·Sae Kamamoto, Akihiko Ozaki, Anju Murayama	5
3	Characteristics of Japanese physician influencers on Twitter during the COVID-19 pandemic and fact-checking their tweets on COVID-19-related drugs 2023 ·Postgraduate Medical Journal ·(unknown), Tetsuya Tanimoto, Sae Kamamoto, Akihiko Ozaki, (unknown), (unknown), Anju Murayama, (unknown), Kazuko Uno	2
4	Characteristics and Distribution of Scholarship Donations From Pharmaceutical Companies to Japanese Healthcare Institutions in 2017: A Cross-sectional Analysis 2023 ·International Journal of Health Policy and Management ·Anju Murayama, Sae Kamamoto, Hiroaki Saito, Erika Yamashita, (unknown), Tetsuya Tanimoto, Piotr Ozierański, Akihiko Ozaki	4
5	Research and Nonresearch Industry Payments to Nephrologists in the United States between 2014 and 2021 2023 ·Journal of the American Society of Nephrology ·Anju Murayama, Sae Kamamoto, (unknown), Hiroaki Saito, Akihiko Ozaki	15
6	Cross-sectional analysis of pharmaceutical payments to Japanese board-certified gastroenterologists between 2016 and 2019 2023 ·BMJ Open ·Anju Murayama, Sae Kamamoto, (unknown), Hiroaki Saito, Erika Yamashita, Tetsuya Tanimoto, Akihiko Ozaki	12
7	Pharmaceutical payments to Japanese board-certified dermatologists: a 4-year retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019 2023 ·Scientific Reports ·Anju Murayama, Sae Kamamoto, Hiroaki Saito, Akihiko Ozaki	11
8	Evaluation of non-research payments from pharmaceutical companies to urologists in Japan between 2016 and 2019 2023 ·International Urogynecology Journal ·Anju Murayama, Hiroaki Saito, Sae Kamamoto, (unknown), Erika Yamashita, Tetsuya Tanimoto, Akihiko Ozaki	7
9	Industry Payments During the COVID-19 Pandemic to Cardiologists in the United States 2023 ·CJC Open ·Anju Murayama, Sae Kamamoto, (unknown), Akihiko Ozaki	13
10	Evaluation of Financial Conflicts of Interest and Quality of Evidence Underlying the American Diabetes Association Clinical Practice Guidelines: The Standards of Medical Care in Diabetes, 2021 2023 ·Cureus ·(unknown), Anju Murayama, Sae Kamamoto, Hiroaki Saito, Akihiko Ozaki	3
11	Nature and Trends in Personal Payments Made to the Respiratory Physicians by Pharmaceutical Companies in Japan between 2016 and 2019 2022 ·Respiration ·Anju Murayama, (unknown), Hiroaki Saito, Sae Kamamoto, (unknown), (unknown), (unknown), Eiji Kusumi, Binaya Sapkota, Sunil Shrestha, Rajeev Shrestha, Divya Bhandari, Toyoaki Sawano, Erika Yamashita, Tetsuya Tanimoto, Akihiko Ozaki	18
12	Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019 2022 ·International Journal of Environmental Research and Public Health ·Anju Murayama, Sae Kamamoto, Hiroaki Saito, (unknown), Divya Bhandari, (unknown), (unknown), (unknown), Erika Yamashita, Eiji Kusumi, Toyoaki Sawano, Binaya Sapkota, Tetsuya Tanimoto, Akihiko Ozaki	16
13	Evaluation of financial conflicts of interest and quality of evidence in Japanese gastroenterology clinical practice guidelines 2022 ·Journal of Gastroenterology and Hepatology ·Anju Murayama, Sae Kamamoto, (unknown), Ryota Yamasaki, (unknown), Erika Yamashita, Hiroaki Saito, Tetsuya Tanimoto, Akihiko Ozaki	14
14	Evaluation of Financial and Nonfinancial Conflicts of Interest and Quality of Evidence Underlying Psoriatic Arthritis Clinical Practice Guidelines: Analysis of Personal Payments From Pharmaceutical Companies and Authors’ Self‐Citation Rate in Japan and the United States 2022 ·Arthritis Care & Research ·(unknown), Anju Murayama, Sae Kamamoto, Yudai Kaneda, Makoto Yoshida, (unknown), Erika Yamashita, Eiji Kusumi, Hiroaki Saito, Toyoaki Sawano, Tetsuya Tanimoto, Matt Vassar, Piotr Ozierański, Akihiko Ozaki	14
15	Trends in Industry Payments to Diabetologists and Endocrinologists in the United States During the COVID-19 Pandemic 2022 ·Cureus ·Anju Murayama, Sae Kamamoto, Hiroaki Saito, Tetsuya Tanimoto, Akihiko Ozaki	4
16	Industry payments to allergists and clinical immunologists in the United States during the coronavirus disease 2019 pandemic 2022 ·Annals of Allergy Asthma & Immunology ·Anju Murayama, Sae Kamamoto, Hiroaki Saito, Tetsuya Tanimoto, Akihiko Ozaki	18
17	Trend in industry payments to infectious disease physicians in the United States: a seven-year analysis of nonresearch payments from the Open Payments Database between 2014 and 2020 2022 ·Clinical Microbiology and Infection ·Anju Murayama, (unknown), Sae Kamamoto, (unknown), Hiroaki Saito, Tetsuya Tanimoto, Akihiko Ozaki	18
18	The Trend in Industry Payments During the COVID-19 Pandemic Among Gastroenterologists and Hepatologists in the United States 2022 ·Cureus ·Anju Murayama, Sae Kamamoto, Hiroaki Saito, Tetsuya Tanimoto, Akihiko Ozaki	3
19	Evaluation of financial relationships between Japanese certified pediatric hematologist/oncologists and pharmaceutical companies: a cross‐sectional analysis of personal payments from pharmaceutical companies between 2016 and 2019 2022 ·Pediatric Blood & Cancer ·Sae Kamamoto, Anju Murayama, Eiji Kusumi, Makoto Yoshida, Hiroaki Saito, Toyoaki Sawano, Erika Yamashita, Tetsuya Tanimoto, Akihiko Ozaki	13
20	Ubiquitin-like 3 as a new protein-sorting factor for small extracellular vesicles 2022 ·Cell Structure and Function ·(unknown), Tomoaki Kahyo, Sae Kamamoto, (unknown), Bin Chen, (unknown), (unknown), Akikazu Kawase, Kei Koizumi, (unknown), Kazuhito Funai, Norihiko Shiiya, Mitsutoshi Setou	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact